Bupropion and restless legs syndrome: A randomized controlled trial

Journal of the American Board of Family Medicine

Volumn 24, Issue 4, 2011, Pages 422-428

  Bayard, Max ^a   Bailey, Beth ^a   Acharya, Deep ^b   Ambreen, Farhana ^b   Duggal, Sonia ^b   Kaur, Taran ^b   Rahman, Zia Ur ^b   Roller, Kim ^b   Tudiver, Fred ^a  

^a Department of Family Medicine ^*  (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Bupropion; Neurology; Restless legs syndrome

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL RESTLESS LEGS SYNDROME STUDY GROUP SEVERITY SCALE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SPONTANEOUS ABORTION; SUSTAINED DRUG RELEASE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DELAYED-ACTION PREPARATIONS; DEPRESSION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960163261     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2011.04.100173     Document Type: Article

References (12)

1. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160(14):2137-41. (Pubitemid 30482720)
2. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4(2):101-19.
3. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS Epidemiology, Symptoms, And Treatment) Primary Care Study. Sleep Med 2004;5(3):237-46. (Pubitemid 38684217)
4. Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry 2004;75(2):226-30. (Pubitemid 38183528)
5. Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008;170(1):35-42.
6. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005;58(6):510-4. (Pubitemid 41393614)
7. Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008;43(1):70-5.
8. Kim SW, Shin IS, Kim JM, Yang SJ, Shin HY, Yoon JS. Bupropion may improve restless legs syndrome: a report of three cases. Clin Neuropharmacol 2005;28(6):298-301.
9. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4(2):121-32. (Pubitemid 36527232)
10. Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 2004;19(12):1414-23.
11. Winkelman JW, Sethi KD, Kushida CA, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2006;67(6):1034-9. (Pubitemid 44454599)
12. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 1999;319(7211):670-4. (Pubitemid 29423954)